AMUSSEN HUNSAKER ASSOCIATES LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMUSSEN HUNSAKER ASSOCIATES LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$52,000
+57.6%
17,0900.0%0.02%
+13.6%
Q1 2020$33,000
-32.7%
17,0900.0%0.02%
-21.4%
Q4 2019$49,000
-31.0%
17,0900.0%0.03%
-40.4%
Q2 2019$71,000
+20.3%
17,0900.0%0.05%
+6.8%
Q4 2018$59,000
-25.3%
17,0900.0%0.04%
-13.7%
Q3 2018$79,000
+1875.0%
17,090
+2376.8%
0.05%
+1600.0%
Q2 2018$4,0006900.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders